Business ❯Finance ❯Corporate Finance ❯Pharmaceuticals

Eli Lilly

Eli Lilly Reports Mixed Q4 Results as Key Drug Sales Fall Short of Expectations

Eli Lilly's Q2 Earnings Surge on High Demand for Weight-Loss Drugs